Home › Glioblastoma › North Carolina › Durham
Studi clinici su Glioblastoma a Durham, NC
20 studi su Glioblastoma cercano partecipanti presso sedi a Durham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
In reclutamentoFase 3
- University of North Carolina, Chapel Hill · a 10 mi di distanza
Targeted Pediatric High-Grade Glioma Therapy
In reclutamentoStudio osservazionale
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
In reclutamentoFase 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
In reclutamentoFase 3
- Duke Cancer Institute, Durham
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
In reclutamentoFase 1
- Duke University Medical Center, Durham
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
In reclutamentoFase 2
- Duke University Medical Center, Durham
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
In reclutamentoFase 2
- Duke University, Durham
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
In reclutamentoFase 2
- Duke University, Durham
Lerapolturev (PVSRIPO) in GBM
In reclutamentoFase 2
- Duke University Medical Center, Durham
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
In reclutamentoFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
In reclutamentoFase 1 inizialeVolontari sani benvenuti
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
In reclutamentoFase 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
In reclutamentoFase 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
In reclutamentoFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
In reclutamentoStudio osservazionale
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi di distanza
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
In reclutamentoFase 1
- Duke University Medical Center, Durham
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
In reclutamentoFase 1/2
- Duke University Medical Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
In reclutamentoFase 2
- University of North Carolina, Chapel Hill · a 10 mi di distanza
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
In reclutamentoFase 1
- Duke University, Durham
Studi su Glioblastoma in altre città
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX26 studi
- Los Angeles, CA24 studi
- San Francisco, CA17 studi
- Chicago, IL15 studi
- Washington, DC15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Rochester, MN13 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Altri studi a Durham
- Cancro al seno64 studi
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule39 studi
- Mieloma multiplo37 studi
- Leucemia mieloide acuta33 studi
- Cancro metastatico33 studi
- Cancro alla prostata32 studi
- Cancro ai polmoni32 studi
- Cancro colorettale28 studi
- Cancro ovarico27 studi
- Leucemia linfatica cronica27 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.